James Joaquin
Investing Profile
Obvious Ventures thesis
We founded Obvious on a simple belief that the most valuable companies of our time will be the ones solving humanity’s biggest problems. Our purpose is to support the world positive entrepreneurs building these disruptive solutions. Together we can reimagine huge sectors of the global economy in ways that move the planet forward. We place great value on values and culture. We hold ourselves and our companies to the highest ethical and moral standards. We select for, and cultivate, values-based leadership across our entire portfolio. We practice humility by reminding ourselves we’re not perfect
Sector and stage focus
- Seed: MarketingTech, Consumer Health
- Series A: Consumer Health, MarketingTech
- general: San Francisco Bay Area
Recent investments by James Joaquin
James Joaquin has 7 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Obello | Seed | Nov 2025 | $9M |
| Parallel Learning | Series A | May 2022 | $20M |
| All In Foods | Series Unknown | Jun 2025 | $4M |
| MycoMedica Life Sciences, PBC | Series A | Jun 2022 | $60M |
| Baton Market | Series A | Jan 2025 | $10M |
| Nectar | Series A | Dec 2022 | $17M |
| NUE Life Health | Series A | Apr 2022 | $23M |
Frequent co-investors
James Joaquin has co-invested with: Matt Mullenweg, Jon Callaghan.
Is James Joaquin a fit for your round?
Upload your pitch deck and see whether James Joaquin appears in your top 20 matches.
Find investors for your deck